Skip to content

Analysis of risk factors and prediction model of disease progression in people with impaired glucose tolerance (IGT)

Analysis of risk factors and prediction model of disease progression in people with impaired glucose tolerance (IGT)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2100004224
Enrollment
Unknown
Registered
2020-11-18
Start date
2020-11-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired glucose tolerance

Interventions

Sponsors

The Affiliated Hospital of Changchun University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. People with impaired glucose tolerance; 1) Aged 18 to 75 years; 2) Meet the diagnostic criteria of Western medicine for IGT; 4) Informed consent has been signed. 2. Healthy people: 1)Aged 18 to 70 years; 2) According to the diagnostic criteria of healthy people, the constitution of traditional Chinese medicine was judged as peaceful constitution; 3) There was no history of chronic diseases, such as diabetes and its pre status, hypertension, hyperlipidemia, hyperuricemia, overweight / obesity, coronary heart disease, etc; 4) Physical examination and blood glucose test data were normal; 5) Informed consent has been signed.

Exclusion criteria

Exclusion criteria: 1) People who have used hypoglycemic drugs continuously in recent 3 months; 2) Patients who have been diagnosed with type 1 diabetes, type 2 diabetes, gestational diabetes, secondary diabetes and other special types of diabetes; 3) Patients with severe other diseases or mental disorders; 4) Due to the poor compliance of the protocol, the researcher considered that it was not suitable to participate in the study; 5) Pregnant or lactating women and those who have recently had family planning; 6) Patients with impaired liver and kidney function (ALT and AST are twice higher than the upper limit of normal value, and serum creatinine is abnormal).

Design outcomes

Primary

MeasureTime frame
Incidence of diabetes mellitus;

Secondary

MeasureTime frame
blood pressure;Fasting and 2-hour postprandial blood glucose;Constitution of traditional Chinese Medicine;liver function;glycosylated hemoglobin;Waist hip ratio;renal function;Insulin resistance index(HOMA-IR);Fasting insulin;the routine urine test;Stool routine;routine blood test;Syndrome of traditional Chinese Medicine;Blood?lipid;Body mass index;

Countries

China

Contacts

Public ContactXiuge Wang
362730191@qq.com+86 0431-86177011

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026